RECRUITING

CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury

Description

The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days

Conditions

Supra-sacral Spinal Cord InjurySpinal Cord InjuryUrinary Incontinence
Talk to us

Related Conditions:

Supra-sacral Spinal Cord InjurySpinal Cord InjuryUrinary Incontinence

Study Overview

On this page

Study Details

Study overview

The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days

Cannabinoid Modulation for Neurogenic Lower Urinary Tract Dysfunction in Spinal Cord Injury

CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury

Condition
Supra-sacral Spinal Cord Injury
Intervention / Treatment

-

Contacts and Locations

Madison

University of Wisconsin - Madison, Madison, Wisconsin, United States, 53705

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * \>18 years of age
  • * History of supra-sacral spinal cord injury of any mechanism
  • * Urinary incontinence with ≥2 episodes of urinary incontinence per day (outside of spinal shock)
  • * Willingness to participate in drug intervention trial
  • * English-speaking (able to provide consent and complete questionnaires)
  • * History of intravesical Botox
  • * Actively taking \>15 mg of Oxybutynin single dose or equivalent dose of alternative anticholinergic medication for bladder symptoms
  • * Use of Cannabis (any form) outside of study as determined by urine drug screen after washout period of 1 month if prior Cannabis use reported
  • * Thought or mood disorder aside from depression

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Wisconsin, Madison,

Javi Santiago, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

2027-01